2024 Australia Infectious Disease Testing Market Shares-Competitive Analysis of Leading and Emerging Market Players
This new report provides infectious diseases testing market shares.
The report analyses current and emerging suppliers of infectious diseases testing analyzers and reagents, including their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies. The companies profiled in the report include:
Abbott
Agilent Technologies
Applied Gene Technologies
Arca Biopharma
Beckman Coulter/Danaher
Becton Dickinson
Biokit
bioMerieux
Bio-Rad
Decode Genetics
Eiken Chemical
Elitech Group
Enzo Biochem
Exact Sciences
Fujifilm Wako
Fujirebio
Grifols
Hologic
Illumina
LabCorp
Leica Biosystems/Kreatech
Li-Cor Biosciences
Myriad Genetics
Proteome Sciences
Qiagen
Quest Diagnostics
QuidelOrtho
Roche
Scienion
Shimadzu
Siemens Healthineers
Takara Bio
Tecan Group
Thermo Fisher
The report analyses current and emerging suppliers of infectious diseases testing analyzers and reagents, including their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies. The companies profiled in the report include:
Abbott
Agilent Technologies
Applied Gene Technologies
Arca Biopharma
Beckman Coulter/Danaher
Becton Dickinson
Biokit
bioMerieux
Bio-Rad
Decode Genetics
Eiken Chemical
Elitech Group
Enzo Biochem
Exact Sciences
Fujifilm Wako
Fujirebio
Grifols
Hologic
Illumina
LabCorp
Leica Biosystems/Kreatech
Li-Cor Biosciences
Myriad Genetics
Proteome Sciences
Qiagen
Quest Diagnostics
QuidelOrtho
Roche
Scienion
Shimadzu
Siemens Healthineers
Takara Bio
Tecan Group
Thermo Fisher
More Publications
Australia Clinical Chemistry Reagents and Analyzers Market Analysis, 2019-2023: Supplier Strategies, Volume and Sales Segment Forecasts, Technology and Instrumentation Review
US$ 3,750.00
May 2019
517 pages
2021-2026 Australia Coagulation Market Database-Supplier Shares, Volume and Sales Segment Forecasts for 40 Hemostasis Tests
US$ 1,500.00
December 2021
-
2024 Australia Tumor Marker Sales Segment Forecasts: Supplier Shares and Strategies, Emerging Tests, Technologies and Opportunities
US$ 3,500.00
June 2020
535 pages
